All News #Library
Biotech
ISA reports highlights of randomized Phase 2 cancer vaccine trial in neck cancer
12 Dec 2023 //
PR NEWSWIRE
ISA`s cancer vaccine fails in ph. 2, Regeneron loses interest
12 Dec 2023 //
FIERCE BIOTECH
First Patient with Chronic Hep B Dosed with ISA104 in First-in-Human Ph 1 Study
31 Aug 2023 //
PR NEWSWIRE
The combination of ISA101b and Libtayo® shows promising results
06 Jun 2023 //
PR NEWSWIRE
ISA Pharmaceuticals to Present First Trial Data from Phase II Study of ISA101b
25 May 2023 //
PR NEWSWIRE
ISA to Present Pre-clinical Data on its Protective SLP Therapy SARS-CoV-2
27 Apr 2023 //
PR NEWSWIRE
ISA and Cancer Focus Fund Announce $5 Million Investment to Support ISA103
04 Jan 2023 //
PR NEWSWIRE

Market Place
Sourcing Support